The role of inflammation in colon cancer (Q38211073)

31 August 2017

The role of inflammation in colon cancer (English)

1 reference

31 August 2017

0 references

Naveena B Janakiram

1

1 reference

PubMed ID

24818718

31 August 2017

Chinthalapally V Rao

series ordinal

2

1 reference

PubMed ID

24818718

31 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Advances in Experimental Medicine and Biology

31 August 2017

1 reference

31 August 2017

816

1 reference

31 August 2017

25-52

1 reference

Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages

31 August 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

What happened to the coxibs on the way to the cardiologist?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Celecoxib for the prevention of colorectal adenomatous polyps

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

NF-kappaB in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Free radicals and the etiology of colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Characterization of a new rat urinary metabolite of piperine by LC/NMR/MS studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

A randomized trial of aspirin to prevent colorectal adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

COX-2: a molecular target for colorectal cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Prooxidant states and tumor promotion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

At the crossroads of inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Resveratrol bioavailability and toxicity in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Patented antiinflammatory plant drug development from traditional medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

The immunobiology of cancer immunosurveillance and immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin use and p53 expression in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

The prevention of colorectal cancer by aspirin use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Curcumin as "Curecumin": from kitchen to clinic.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Free radicals and carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Altered inflammatory responses in leukotriene-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Colorectal cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Nitric oxide in cancer and chemoprevention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

iNOS-selective inhibitors for cancer prevention: promise and progress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Determination of dihydroresveratrol in rat plasma by HPLC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Colorectal cancer chemoprevention by trans-resveratrol

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

In vivo and in vitro studies of hypocholesterolemic effects of diosgenin in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin and colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Pharmacology of oleanolic acid and ursolic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Advances in triterpenoid research, 1990-1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin prevents tumors in a murine model of familial adenomatous polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Sulindac enhances cell proliferation in DMH-treated mouse colonic mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Nonsteroidal antiinflammatory drugs and colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Effect of spices on lipid metabolism in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Acute and subacute toxicity of piperine in mice, rats and hamsters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Treatment of Chemically-Induced Intestinal Cancers with Indomethacin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Nitric oxide signaling in colon cancer chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

NSAIDs and chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Effects of Long-term Sulindac Therapy on Colonic Polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Sulindac inhibits the rate of growth and appearance of colon tumors in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cyclooxygenases: structural, cellular, and molecular biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin use, cancer, and polyps of the large bowel

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrate/nitrite levels, and lower protection against oxygen free radicals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

New insights into the aetiology of colorectal cancer from genome-wide association studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Aspirin use and reduced risk of fatal colon cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Sulindac for polyposis of the colon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Cytokines in colitis associated cancer: potential drug targets?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Bioavailability of resveratrol

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Prostaglandins and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Intestinal mucosal inflammation leads to systemic genotoxicity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Microencapsulated iNOS-expressing cells cause tumor suppression in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Increased in situ expression of nitric oxide synthase in human colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_2

Diosgenin, a Steroid Saponin of Trigonella foenum graecum (Fenugreek), Inhibits Azoxymethane-Induced Aberrant Crypt Foci Formation in F344 Rats and Induces Apoptosis in HT-29 Human Colon Cancer Cells

31 March 2020

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1158/1055-9965.1392.13.8

Identifiers

DOI

10.1007/978-3-0348-0837-8_2

1 reference

31 August 2017

1 reference

PubMed ID

24818718